AdvaMed - Advanced Medical Technology Association

11/14/2024 | Press release | Distributed by Public on 11/14/2024 10:30

Healionics’ STARgraft Receives FDA Breakthrough Device Designation

Press Releases

Healionics' STARgraft Receives FDA Breakthrough Device Designation

  • EIN Presswire
  • November 14, 2024

Seattle, WA, November 14, 2024 / EINPresswire.com /- Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced that its STARgraft arteriovenous graft - designed to provide a safer and more reliable means of bloodstream access for kidney failure patients needing dialysis - has been granted Breakthrough Device designation by the FDA.

Read more.

Call to Action…